Home / AREVF : OTC

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does AREVF make money? Does AREVF have pricing power? What's the Earnings Whisper? Will AREVF profit more as the business scales? What is AREVF's management track record? Is AREVF's current price justified?

AREV Life Sciences Global Corp

$0 -$0.00 (-0.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.01

Year Range

$0$0.01

Market Cap

15.88K

AVG Volume

9.33K

Trailing/Forward PE

-1.87/-

PEG ratio

-0.03

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

AREVF Revenue (CAD) by quarter
Period	Revenue (CAD)
23 Q3	0
23 Q2	0
23 Q1	0
22 Q4	7.21K
22 Q3	23.09K
22 Q2	10.19K
22 Q1	8.63K
21 Q4	141.99K
21 Q3	26.48K
21 Q2	43.19K

Net Income (CAD)

AREVF Net Income (CAD) by quarter
Period	Net Income (CAD)
23 Q3	-28.93K
23 Q2	-120.83K
23 Q1	-169.37K
22 Q4	79.58K
22 Q3	-240.65K
22 Q2	-772.94K
22 Q1	-510.09K
21 Q4	501.62K
21 Q3	-219.91K
21 Q2	-695.26K

Operating Income (CAD)

AREVF Operating Income (CAD) by quarter
Period	Operating Income (CAD)
23 Q3	-11.98K
23 Q2	-119.53K
23 Q1	-166.03K
22 Q4	103.11K
22 Q3	-219.81K
22 Q2	-770.33K
22 Q1	-507.72K
21 Q4	-221.95K
21 Q3	-203.5K
21 Q2	-678.8K

EBITDA (CAD)

AREVF EBITDA (CAD) by quarter
Period	EBITDA (CAD)
23 Q3	-14.14K
23 Q2	-106.05K
23 Q1	-154.59K
22 Q4	109.56K
22 Q3	-188.78K
22 Q2	-737.91K
22 Q1	-477.3K
21 Q4	546.48K
21 Q3	-171.78K
21 Q2	-646.1K

Cash Flows (CAD)

AREVF Cash Flows (CAD) by quarter
Period	Cash Flows (CAD)
23 Q3	-5.58K
23 Q2	-115.79K
23 Q1	-24.99K
22 Q4	-7K
22 Q3	-5.07K
22 Q2	-167.16K
22 Q1	-186.97K
21 Q4	-56.62K
21 Q3	-61.26K
21 Q2	-871.84K

EPS (CAD)

AREVF EPS (CAD) by quarter
Period	EPS (CAD)
23 Q3	-0
23 Q2	-0
23 Q1	-0.01
22 Q4	0
22 Q3	-0.01
22 Q2	-0.03
22 Q1	-0.02
21 Q4	0.02
21 Q3	-0.01
21 Q2	-0.03

Expenses (CAD)

AREVF Expenses (CAD) by quarter
Period	Expenses (CAD)
23 Q3	-1.86K
23 Q2	101.22K
23 Q1	145.62K
22 Q4	-136.71K
22 Q3	224.07K
22 Q2	786.62K
22 Q1	512.63K
21 Q4	288.16K
21 Q3	206.32K
21 Q2	723.17K

Cash & Debt (CAD)

AREVF Cash & Debt (CAD) by quarter
Period	Cash & Debt (CAD)
23 Q3	1.82K
23 Q2	7.4K
23 Q1	39.28K
22 Q4	94
22 Q3	15.17K
22 Q2	11.23K
22 Q1	18.05K
21 Q4	158.31K
21 Q3	27.4K
21 Q2	87.67K

Debt ratios

AREVF Debt ratios by quarter
Period	Debt ratios
23 Q3	-0.87
23 Q2	-0.41
23 Q1	-0.02
22 Q4	-0.02
22 Q3	-0.04
22 Q2	-0.05
22 Q1	-0.07
21 Q4	0.1
21 Q3	-0.29
21 Q2	-0.27

Margins

AREVF Margins by quarter
Period	Margins
22 Q4	-299.88%
22 Q3	-40.68%
22 Q2	-227.79%
22 Q1	-258.04%
21 Q4	74.96%
21 Q3	-39.96%
21 Q2	12.79%
21 Q1	15.1%
20 Q4	100%
20 Q3	100%

Return on Capital

AREVF Return on Capital by quarter
Period	Return on Capital
23 Q3	2.49%
23 Q2	10.65%
23 Q1	16.71%
22 Q4	-8.35%
22 Q3	28.5%
22 Q2	108.94%
22 Q1	111.44%
21 Q4	-536.45%
21 Q3	24.89%
21 Q2	104.61%

Shares Outstanding

AREVF Shares Outstanding by quarter
Period	Shares Outstanding
23 Q3	31.79M
23 Q2	31.76M
23 Q1	31.72M
22 Q4	31.54M
22 Q3	30.57M
22 Q2	30.24M
22 Q1	28.05M
21 Q4	26.89M
21 Q3	25.43M
21 Q2	25.22M

Book Value Per Share (CAD)

AREVF Book Value Per Share (CAD) by quarter
Period	Book Value Per Share (CAD)
23 Q3	-0.04
23 Q2	-0.04
23 Q1	-0.03
22 Q4	-0.03
22 Q3	-0.03
22 Q2	-0.02
22 Q1	-0.02
21 Q4	-0
21 Q3	-0.03
21 Q2	-0.03

Total Assets (CAD)

AREVF Total Assets (CAD) by quarter
Period	Total Assets (CAD)
23 Q3	213.29K
23 Q2	231.96K
23 Q1	275.05K
22 Q4	252.63K
22 Q3	360.76K
22 Q2	386.85K
22 Q1	407.1K
21 Q4	622.57K
21 Q3	443.29K
21 Q2	580.29K

Free Cash Flow Yield

AREVF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-695.8%
Sep 26	-697.67%
Aug 26	-694.17%
Aug 26	-701.14%
Aug 26	-695.62%
Aug 26	-692.46%
Jul 26	-688.7%
Jul 26	-684.79%
Jul 26	-688.32%
Jul 26	-681.95%
Jul 26	-680.49%
Jun 26	-680.17%
Jun 26	-682.61%
Jun 26	-689.9%
Jun 26	-692.38%
May 26	-699.94%
May 26	-698.52%
May 26	-702.09%
May 26	-705.7%
May 26	-710.32%
Apr 26	-706.17%
Apr 26	-704.96%
Apr 26	-697.31%
Apr 26	-693.36%
Mar 26	-694.74%
Mar 26	-703.43%
Mar 26	-703.34%
Mar 26	-711.69%
Feb 26	-707.6%
Feb 26	-705.76%
Feb 26	-708.85%
Feb 26	-705.93%
Jan 26	-708.74%
Jan 26	-704.55%
Jan 26	-693.57%
Jan 26	-693.74%
Jan 26	-702.97%
Dec 25	-705.88%
Dec 25	-699.47%
Dec 25	-700.81%
Dec 25	-698.55%
Nov 25	-34.54%
Nov 25	-34.23%
Nov 25	-34.42%
Nov 25	-34.35%
Oct 25	-34.46%
Oct 25	-34.48%
Oct 25	-34.42%
Oct 25	-34.47%
Oct 25	-34.6%
Sep 25	-34.62%
Sep 25	-35.04%
Sep 25	-34.85%
Sep 25	-34.9%
Aug 25	-35.12%
Aug 25	-34.91%
Aug 25	-34.93%
Aug 25	-35.08%
Aug 25	-35%
Jul 25	-35.23%
Jul 25	-35.17%
Jul 25	-35.26%
Jul 25	-35.53%
Jun 25	-35.28%
Jun 25	-35.14%
Jun 25	-35.54%
Jun 25	-35.25%
May 25	-35.13%
May 25	-35.15%
May 25	-34.55%
May 25	-34.64%
May 25	-34.93%
Apr 25	-34.84%
Apr 25	-34.88%
Apr 25	-34.81%
Apr 25	-33.92%
Mar 25	-33.71%
Mar 25	-33.63%
Mar 25	-33.58%
Mar 25	-33.6%
Feb 25	-33.37%
Feb 25	-33.94%
Feb 25	-34.03%
Feb 25	-33.78%
Jan 25	-33.23%
Jan 25	-33.65%
Jan 25	-33.33%
Jan 25	-33.47%
Jan 25	-33.41%
Dec 24	-33.49%
Dec 24	-33.58%
Dec 24	-33.91%
Dec 24	-34.1%
Nov 24	-34.47%
Nov 24	-34.54%
Nov 24	-34.26%
Nov 24	-34.7%
Nov 24	-34.6%
Oct 24	-34.74%
Oct 24	-34.97%

Price to Sales

AREVF Price to Sales by quarter
Period	Price to Sales
Sep 26	3.06
Sep 26	3.05
Aug 26	3.06
Aug 26	3.03
Aug 26	3.06
Aug 26	3.07
Jul 26	3.09
Jul 26	3.11
Jul 26	3.09
Jul 26	3.12
Jul 26	3.13
Jun 26	3.13
Jun 26	3.12
Jun 26	3.08
Jun 26	3.07
May 26	3.04
May 26	3.05
May 26	3.03
May 26	3.01
May 26	2.99
Apr 26	3.01
Apr 26	3.02
Apr 26	3.05
Apr 26	3.07
Mar 26	3.06
Mar 26	3.02
Mar 26	3.02
Mar 26	2.99
Feb 26	3.01
Feb 26	3.01
Feb 26	3
Feb 26	3.01
Jan 26	3
Jan 26	3.02
Jan 26	3.07
Jan 26	3.07
Jan 26	3.03
Dec 25	3.01
Dec 25	3.04
Dec 25	3.04
Dec 25	3.05
Nov 25	61.6
Nov 25	62.15
Nov 25	61.81
Nov 25	61.93
Oct 25	61.73
Oct 25	61.7
Oct 25	61.8
Oct 25	61.71
Oct 25	61.48
Sep 25	61.45
Sep 25	60.72
Sep 25	61.04
Sep 25	60.95
Aug 25	60.57
Aug 25	60.93
Aug 25	60.91
Aug 25	60.64
Aug 25	60.79
Jul 25	60.39
Jul 25	60.49
Jul 25	60.34
Jul 25	59.88
Jun 25	60.3
Jun 25	60.55
Jun 25	59.87
Jun 25	60.35
May 25	60.56
May 25	60.52
May 25	61.57
May 25	61.42
May 25	60.9
Apr 25	61.06
Apr 25	60.99
Apr 25	61.12
Apr 25	62.72
Mar 25	63.1
Mar 25	63.27
Mar 25	63.35
Mar 25	63.32
Feb 25	63.75
Feb 25	62.67
Feb 25	62.52
Feb 25	62.98
Jan 25	64.03
Jan 25	63.22
Jan 25	63.83
Jan 25	63.56
Jan 25	63.68
Dec 24	63.53
Dec 24	63.35
Dec 24	62.73
Dec 24	62.39
Nov 24	61.72
Nov 24	61.6
Nov 24	62.09
Nov 24	61.3
Nov 24	61.48
Oct 24	61.23
Oct 24	60.83

Price/Operating Cashflow

AREVF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 20	23.14
Sep 20	22.82
Sep 20	22.77
Sep 20	22.58
Aug 20	22.54
Aug 20	92.72
Aug 20	93.38
Aug 20	94.18
Jul 20	94.39
Jul 20	94.42
Jul 20	95.59
Jul 20	96.23
Jul 20	96.03

Price to Book

AREVF Price to Book by quarter
Period	Price to Book
Mar 20	0.94
Mar 20	0.96
Mar 20	0.93
Mar 20	2.4
Feb 20	3.39
Feb 20	2.37
Feb 20	2.37
Feb 20	2.71
Jan 20	2.7
Jan 20	2.68
Jan 20	1.64
Jan 20	4.03
Jan 20	4.01

No video analysis for this stock yet. Request one from our team.

AI Analysis

AREV Life Sciences Global Corp

Video analysis: AREVF

Similar companies